Who Paid My Doc
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multic
Research payments
$1,158,290
Through program year 2025, $1,158,290 in research payments was reported against A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multic, across 176 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,158,290 | 176 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Humberto Cruz Orlando, FL Named on 12 payments
- Guillermo Somodevilla Miami, FL Named on 11 payments
- Syed Raza Southfield, MI Named on 5 payments
- Sashi Makam New Windsor, NY Named on 4 payments
- Mireya Garcia Miami, FL Named on 4 payments
- Luis Hernandez Rosado Homestead, FL Named on 4 payments
- David Green Shreveport, LA Named on 4 payments
- Lisa Youkeles Mount Kisco, NY Named on 4 payments
- Patrick Moore Lafayette, LA Named on 4 payments
- Bashar Bargoty Powell, TN Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.